Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 592.22 Delayed Data As of 4:10pm ET |  +16.02 / +2.78%Today’s Change | 441.00 Today|||52-Week Range 686.62 | +22.58% Year-to-Date |
Latest REGN News | Press Releases
Today’s Trading
| Previous close | 576.20 |
| Today’s open | 579.86 |
| Day’s range | 575.37 - 594.20 |
| Volume | 44,219 |
| Average volume (3 months) | 778,250 |
| Market cap | $61.2B |
Data as of 4:10pm ET, 10/26/2021
Growth & Valuation
| Earnings growth (last year) | +68.51% |
| Earnings growth (this year) | +99.70% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +8.06% |
| P/E ratio | 10.7 |
| Price/Sales | 6.54 |
| Price/Book | 5.55 |
Financials
| Next reporting date | November 4, 2021 |
| EPS forecast (this quarter) | $10.17 |
| Annual revenue (last year) | $8.5B |
| Annual profit (last year) | $3.5B |
| Net profit margin | 41.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
